Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of cortico-meningeal translocator protein expression in multiple sclerosis.
Herranz E, Treaba CA, Barletta VT, Mehndiratta A, Ouellette R, Sloane JA, Ionete C, Babu S, Mastantuono M, Magon S, Loggia ML, Makary MM, Hooker JM, Catana C, Kinkel RP, Nicholas R, Klawiter EC, Magliozzi R, Mainero C. Herranz E, et al. Among authors: hooker jm. Brain. 2024 Jul 5;147(7):2566-2578. doi: 10.1093/brain/awae030. Brain. 2024. PMID: 38289855
Toward AI-driven neuroepigenetic imaging biomarker for alcohol use disorder: A proof-of-concept study.
Dagnew TM, Tseng CJ, Yoo CH, Makary MM, Goodheart AE, Striar R, Meyer TN, Rattray AK, Kang L, Wolf KA, Fiedler SA, Tocci D, Shapiro H, Provost S, Sultana E, Liu Y, Ding W, Chen P, Kubicki M, Shen S, Catana C, Zürcher NR, Wey HY, Hooker JM, Weiss RD, Wang C. Dagnew TM, et al. Among authors: hooker jm. iScience. 2024 May 31;27(7):110159. doi: 10.1016/j.isci.2024.110159. eCollection 2024 Jul 19. iScience. 2024. PMID: 39021792 Free PMC article.
Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia.
Rosenthal ZC, Fass DM, Payne NC, She A, Patnaik D, Hennig KM, Tesla R, Werthmann GC, Guhl C, Reis SA, Wang X, Chen Y, Placzek M, Williams NS, Hooker J, Herz J, Mazitschek R, Haggarty SJ. Rosenthal ZC, et al. Sci Rep. 2024 Apr 20;14(1):9064. doi: 10.1038/s41598-024-59110-7. Sci Rep. 2024. PMID: 38643236 Free PMC article.
A functional account of stimulation-based aerobic glycolysis and its role in interpreting BOLD signal intensity increases in neuroimaging experiments.
Theriault JE, Shaffer C, Dienel GA, Sander CY, Hooker JM, Dickerson BC, Barrett LF, Quigley KS. Theriault JE, et al. Among authors: hooker jm. Neurosci Biobehav Rev. 2023 Oct;153:105373. doi: 10.1016/j.neubiorev.2023.105373. Epub 2023 Aug 25. Neurosci Biobehav Rev. 2023. PMID: 37634556 Free PMC article. Review.
Novel multi-modal methodology to investigate placebo response in major depressive disorder.
Cusin C, Dillon DG, Belleau E, Normandin MD, Petibon Y, El-Fakri G, Dhaynaut M, Hooker J, Kaptchuk T, McKee M, Hayden E, Meyer A, Jahan A, Origlio J, Ang YS, Brunner D, Kang M, Long Y, Fava M, Pizzagalli DA. Cusin C, et al. J Affect Disord. 2025 Jan 1;368:1-7. doi: 10.1016/j.jad.2024.08.226. Epub 2024 Sep 2. J Affect Disord. 2025. PMID: 39233242 Clinical Trial.
Psychedelics and Entactogens: Call for Papers.
Lindsley CW, Hooker JM, Chibale K, Müller CE, Booker SJ. Lindsley CW, et al. Among authors: hooker jm. J Med Chem. 2024 Nov 25. doi: 10.1021/acs.jmedchem.4c02794. Online ahead of print. J Med Chem. 2024. PMID: 39585657 No abstract available.
213 results